NUE vs TNXP · P/E 25, rev $19.89B vs rev $20.4M
Nucor Corp (NUE) versus Tonix Pharmaceuticals Holding Corp (TNXP) — a side-by-side from cached financials, not a winner call.
Nucor Corp (NUE) is a steel company listed on NYSE.
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Latest reported TNXP revenue for 2026-06-30 was $20.4M. Net income was -$80.7M. TNXP currently screens at market cap $194.5M.
NUE currently screens at market cap $57.53B and trailing P/E 25.1. TNXP currently screens at market cap $194.5M.
Not investment advice. Open the NUE and TNXP stock pages for the full models.
Not investment advice.